Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Had a stillbirth on Saturday 12Jun2021, this is the 33rd week of pregnancy; This is a spontaneous report from a contactable consumer or other non hcp via Pfizer colleague. This consumer or other non hcp reported information for both mother and fetus. This is a maternal report. A 35-years-old female patient received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Expiry Date: unknown, Batch/Lot number: unknown), via an unspecified route of administration on 06Mar2021 as single dose for covid-19 immunization. The patient''s medical history and concomitant medications were not reported. Previously, the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection; Expiry Date: unknown, Lot number: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. On 12Jun2021 Saturday, the patient had stillbirth and was in 33rd week of pregnancy. A genetic disease diagnosed by biochemical tests or DNA tests shown PTEN Hamartoma tumor syndrome, macrocephaly. The patient would like to respect her reques for privacy and medical confidentiality. The patient was also not interested in received messages and telephone calls in near future. Info about lot/batch will be asked upon FU.; Sender''s Comments: Linked Report(s) : IL-PFIZER INC-2021720556 mother/fetus case
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166